Episode 90 & 91 of Innovate Fort Worth is LIVE!
In this week’s episode, HSC Next interviews Danguole Altman, the CEO of CX Precision Medicine. More than 6 million Americans are living with Alzheimer’s Disease. Cx Precision Medicine’s CEO, Danguole Altman, is focused on tackling this big problem for an aging population. Based on Dr. Sid O’Bryant’s revolutionary research at HSC, Cx Precision Medicine is bringing this important diagnostic technology to help people all over the world. Through a clinical diagnostic, Cx Precision Medicine is conducting screening tests to detect Alzheimer’s and other neurodegenerative diseases based on blood biomarkers, AI and machine learning. Cx aims to “Change eXpectations” around how doctors diagnose Alzheimer’s and dementia.
Get to know how CX Precision Medicine is innovating biotech by listening to “Innovate Fort Worth” wherever you find your podcast, or watch the interview on Youtube!
Watch here for Part 1 with Danguole Altman: https://youtu.be/fFtUlG7z_NE
Watch here for Part 2 with Danguole Altman: https://youtu.be/JmcJBK8Hyjs
Watch here for Part 1 with Dr. Sid O’Bryant: https://youtu.be/_Hshnlnm47k
Watch here for Part 2 with Dr. Sid O’Bryant: https://youtu.be/HnpmBc7g9u4
To learn more about Cx Precision Medicine, visit their website at https://cxprecisionm.com
Have a question, comment, or recommendation, email us at hello@hscnext.com
Learn more how HSC Next supports your innovative ideas, visit our resources at hscnext.com.